Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
about
Phenylketonuria: a review of current and future treatmentsAdvances in the nutritional and pharmacological management of phenylketonuriaPhenylketonuria: translating research into novel therapiesInduced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice.Amino Acid Medical Foods Provide a High Dietary Acid Load and Increase Urinary Excretion of Renal Net Acid, Calcium, and Magnesium Compared with Glycomacropeptide Medical Foods in Phenylketonuria.Metabolome-wide association study of phenylalanine in plasma of common marmosetsGlycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice.Analysis of the functional muscle-bone unit of the forearm in patients with phenylketonuria by peripheral quantitative computed tomography.The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?The Use of Glycomacropeptide in Dietary Management of Phenylketonuria.The complete European guidelines on phenylketonuria: diagnosis and treatment.Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.Does the PKU diet contribute to impaired renal function?Dietary intervention in the management of phenylketonuria: current perspectives.Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
P2860
Q26770291-A1FC56AF-03E0-4928-A303-6890AEB6B4F9Q27006137-8A6C66A8-ACCA-4DFE-8088-D2D1D14D36AEQ27015749-F7F559B8-E525-4C73-BC5C-5E3AEE10E2C2Q33649249-54571F8C-2DBA-47A0-B942-B4BDD61E3EC4Q33701791-34B6E01E-8511-454E-9D33-53CBBEE643F3Q35085238-3D1F89C2-8889-4A61-806D-85AE0A6E0F96Q35739492-3EB265F2-EE46-4413-8300-13047D2E98E3Q36150933-65CF4791-8A75-4980-9271-3BE420D2AFC1Q36202127-4C97DA52-775D-4267-AFFD-5D1860A33C9EQ36517618-C0CB6EDC-980F-4FFD-889D-45B12B006314Q39006197-002B5CC9-D7FD-458D-A5CD-0F5393602E02Q39676007-35AA57CE-EF0A-468B-BFC1-5F4605E40F18Q42376686-B2CD5946-EA09-4306-B790-3927C2ADEA30Q42401605-DD544E00-573D-4E1F-86E7-CD91BF1A0510Q45905282-A7A7986D-A7DD-4DEE-8170-78E4C0151691Q49500552-499B168D-9CEA-4A95-9C01-58DEF80D9796Q50733179-8A84AE74-58E7-4F33-BEB2-343A270C0447
P2860
Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@ast
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@en
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@nl
type
label
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@ast
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@en
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@nl
prefLabel
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@ast
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@en
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@nl
P2093
P2860
P1433
P1476
Low bone strength is a manifes ...... d by a glycomacropeptide diet.
@en
P2093
Denise M Ney
Patrick Solverson
Robert D Blank
Sangita G Murali
Suzanne J Litscher
P2860
P304
P356
10.1371/JOURNAL.PONE.0045165
P407
P577
2012-09-18T00:00:00Z